Form 4: Sabra Health Care REIT Director Receives Equity Grant, Boosting Aligned Interests

Sabra Health Care REIT, Inc. Director Craig A. Barbarosh was granted 8,178 restricted stock units, aligning his interests with shareholders.

Summary

• Craig A. Barbarosh, a Director of Sabra Health Care REIT, Inc. (SBRA), was granted 8,178 restricted stock units (RSUs) on June 12, 2025.
• The RSUs were granted under the Issuer's 2009 Performance Incentive Plan at a price of $0 per unit, which is typical for equity grants.
• These units will vest in equal monthly installments starting July 12, 2025, and concluding on the earlier of June 12, 2026, or the day before the next annual stockholders' meeting.
• Following this transaction, Mr. Barbarosh directly beneficially owns 51,797 common shares, consisting of the 8,178 newly granted unvested RSUs and 43,619 vested but deferred stock units.
• Additionally, Mr. Barbarosh indirectly beneficially owns 94,916 common shares through The Barbarosh Family Trust.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the equity grant aligns the director's interests with shareholders, which is generally viewed favorably, though it's a routine compensation event.

Positives

• The grant of restricted stock units to Director Craig A. Barbarosh aligns his financial interests more closely with those of the company's shareholders.
• Equity compensation is a standard practice that incentivizes long-term performance and commitment from key personnel.

Future Outlook

The granted restricted stock units are set to vest in equal monthly installments beginning July 12, 2025, and concluding by June 12, 2026, or prior to the next annual stockholders' meeting.

Industry Context

This transaction is a routine equity compensation event for a director in the Real Estate Investment Trust (REIT) sector, a common practice to align management incentives with shareholder value creation. Such grants are standard across various industries, including healthcare REITs, to retain talent and encourage long-term strategic focus.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) as a form of executive compensation is a widely adopted practice across the REIT industry and broader public companies, aligning director interests with long-term shareholder value.
• The vesting schedule, tied to a future date or the next annual meeting, is a typical structure for such grants, similar to compensation practices observed in comparable healthcare REITs.

Related Party Transactions

• Indirect beneficial ownership of 94,916 common shares is held through The Barbarosh Family Trust.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's long-term interests with shareholder value creation, potentially leading to more focused strategic decisions.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• The restricted stock units will begin vesting in equal monthly installments starting July 12, 2025.

Key Dates

Keywords

Sabra Health Care REIT, SBRA, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Executive Compensation